When does the clevidipine patent expire?
Patent-expiration timing depends on the specific patent(s) covering clevidipine and the jurisdiction (US vs. other countries). I don’t have the underlying patent numbers or filing/expiry dates in the provided information, so I can’t state an exact expiration date for clevidipine.
How do clevidipine’s exclusivity periods work (patents vs. market exclusivity)?
Even when a drug’s primary patent expires, market exclusivity can still keep generic or biosimilar products off the market for additional periods. The key point is that:
- Patent expiry is tied to specific patents covering the product.
- Regulatory exclusivities (which vary by country and product type) can extend market protection beyond the last patent.
To determine clevidipine’s actual “generic entry” date, you need both the relevant clevidipine patents and any regulatory exclusivity remaining in the target country.
What’s the fastest way to find clevidipine’s exact patent-expiration date?
Look up clevidipine in the relevant patent/exclusivity databases for your country:
- United States: FDA Orange Book (lists patents and “exclusivity” information for approved products).
- Other countries: national patent registers and local regulator exclusivity guidance.
If you tell me the country (for example, US) and the clevidipine brand/manufacturer name you care about, I can help you translate what you find (e.g., “which patent drives earliest expiration” vs. “which exclusivity delays entry”).
What happens after patent expiry—when can generics enter?
Once the controlling patents and any exclusivity end, generic manufacturers can typically submit or launch products subject to regulatory review and labeling requirements. The exact timing hinges on:
- Whether the generic can legally rely on FDA-approved references.
- Remaining exclusivity (if any).
- The status of any patent litigation or negotiated “at-risk” launch pathways (common in US Hatch-Waxman contexts).
Are there different expiration dates for different formulations or strengths?
Yes. Different strengths, dosage forms, or updated formulations can have separate protecting patents and exclusivity terms. Clevidipine’s expiration date could vary depending on which specific product/label configuration you mean.
Sources
No sources were provided with the question, so I’m not able to cite clevidipine-specific expiration dates.